2-[2-[( tert -Butyldimethylsilyl)oxy]ethoxy]ethyl methacrylate ( 2 ) and 2-[2-[2-[( tert -butyldimethylsilyl)oxy]ethoxy]ethoxy]ethyl methacrylate ( 3 ) were polymerized anionically in THF at −78 °C for 2−24 h. The anionic initiator systems included 1,1-diphenyl-3-methylpentyllithium/lithium chloride and diphenylmethylpotassium/diethylzinc. The polymerization of novel tert -butyldimethylsilyl-protected oligo(ethylene glycol) methacrylates, 2 and 3, proceeded quantitatively in each case. The resulting polymers possessed the predicted molecular weights based on the molar ratios of monomers to initiators, and narrow molecular weight distributions ( M w / M n < 1.1). The stability of the propagating carbanion of poly( 2 ) and poly( 3 ) was ascertained by the quantitative efficiencies of the sequential block copolymerizations using tert -butyl methacrylate (tBMA). Well-defined block copolymers, poly( 2 )- block -poly(tBMA) and poly( 3 )- block -poly(tBMA), were obtained. The trialkylsilyl protecting groups of poly( 2 ) and poly( 3 ) were quantitatively hydrolyzed using 2 N HCl in aqueous THF at 0 °C for 2 h to give tailored poly[di(ethylene glycol) methacrylate] and poly[tri(ethylene glycol) methacrylate], respectively. Both polymethacrylates obtained after deprotection were readily soluble in water due to the high polarity of the hydrophilic oligo(ethylene glycol) pendant units with terminal OH functionality.
No takes yet. Share an insight, caveat, or question.
Ishizone et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: